02.05.26 -- STREAM Edition: Contamination Control Strategies For Drug Manufacturers

Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.

Discover how expert database systems for inspection and control help cell and gene therapies meet the requirements of USP-790 to assure they are essentially free from particulate matter.

Review flexible, AI-enhanced visual inspection solutions—from lab to high-volume production—ensuring product quality and patient safety across diverse pharmaceutical formulations and packaging types.

Rushing into small molecule batch production without a comprehensive strategy for contamination control could end up costing a lot more money. Learn about key focus areas for prevention, including site architectural design and HVAC systems.

See how a vendor that offers integrated drug substance, drug product, and clinical testing activities under one organization facilitates improved communication and a more agile approach to development.

Examine how modern quality assurance tools strengthen product reliability in pharmaceutical workflows to detect issues earlier, streamline oversight, and support consistent, high‑quality results.